Catalyst Event
Shanghai Fosun Pharmaceutical (Group) Co Ltd (2196) · Earnings Release
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
4/28/2026, 12:00:00 AM
Announced Q1 2026 results on April 28, 2026, with revenue of RMB 10.07 billion (+6.93% YoY) and net profit attributable to shareholders of RMB 871 million (+13.87% YoY). The 13.87% profit growth is estimated to result in a price impact of at least 10% expected.
Korean Translation
2026년 4월 28일, 2026년 1분기 실적을 발표함. 매출은 100.7억 위안(+6.93%), 주주 귀속 순이익은 8.71억 위안(+13.87%)을 기록함. 13.87%의 이익 성장은 10% 이상의 가격 영향을 미칠 것으로 예상됨.
Related Recent Events
Livzon Pharmaceutical Group Inc (1513) · Other
Ex-dividend date for the final dividend of RMB 1.43 per share for the fiscal year 2025 on 2026-06-16, scheduled.
6/16/2026, 12:00:00 AM
Biocytogen Pharmaceuticals (Beijing) Co Ltd (2315) · Other
Annual General Meeting to be held on 2026-05-21 to review reports and approve plans; routine meetings typically have a 1-5% price impact, scheduled
5/21/2026, 12:00:00 AM
Shanghai Fosun Pharmaceutical (Group) Co Ltd (2196) · Other
An earnings briefing for the 2025 fiscal year and Q1 2026 results is scheduled for May 14, 2026. This routine communication event is estimated to have a price impact of at least 1% scheduled.
5/14/2026, 12:00:00 AM
Caris Life Sciences Inc (CAI) · Earnings Release
Caris Life Sciences to report first quarter 2026 financial results on May 7, 2026, scheduled.
5/7/2026, 12:00:00 AM
Guardant Health Inc (GH) · Earnings Release
Guardant Health is scheduled to release its Q1 2026 financial results after market close on May 7, 2026. Analysts forecast EPS of ($0.47) and revenue of $279.17 million. High importance estimated due to potential for significant volatility following earnings results, scheduled.
5/7/2026, 12:00:00 AM
Natera Inc (NTRA) · Earnings Release
Natera is scheduled to release its first quarter 2026 financial results after the market closes on May 7, 2026, with analysts forecasting revenue of approximately $617.5 million and an EPS of -$0.55; high importance is expected due to typical earnings volatility, scheduled.
5/7/2026, 12:00:00 AM